Leading Practices in Quality & Compliance

Elevating Quality Management Beyond Execution for Strategic Advantage

A Kinapse White Paper
Written by Michael Keech, Jean Samuel and Chunky Satija

Executive summary


Done well, Q&C provides competitive advantage, growth and financial health for the shareholders.

Done poorly, it can mean interruption of supply to customers, long-term decline of a firm’s credibility with various stakeholders, including regulators, external partners, patients and shareholders, and the ultimate demise of the business enterprise.

Fill in the form to download our white paper, learn how to facilitate sustainable Q&C and integrate it into the way your organization lives and breathes.

Download your copy

Fill out the form above to download this White Paper


Build trust among patients, healthcare professionals, payers and regulators
Patient safety is paramount


Ensure data quality
Increase regulatory & payer confidence in quality efficacy, safety and value claims


Decrease resources spent on rework and issue mitigation
Reduce efforts spent on fire-fighting


Avoid non-compliance with regulators and codes of conduct

In many pharmaceutical companies, there is a fundamental disconnect between the business and the role of Quality & Compliance (Q&C).

Nulla dignissim lacus odio

At laoreet ante sollicitudin vel. Phasellus quam pellentesque id facilisis ut, fermentum at ipsum. Proin auctor efficitur vestibulum. Mauris commodo bibendum pulvinar.

Nulla dignissim lacus odio

At laoreet ante sollicitudin vel. Phasellus quam pellentesque id facilisis ut, fermentum at ipsum. Proin auctor efficitur vestibulum. Mauris commodo bibendum pulvinar.

Nulla dignissim lacus odio

At laoreet ante sollicitudin vel. Phasellus quam pellentesque id facilisis ut, fermentum at ipsum. Proin auctor efficitur vestibulum. Mauris commodo bibendum pulvinar.